Although there is evidence that the mTOR pathway acts as a negative regulator of ferroptosis in cancer cells and that the regulation of ferroptosis by mTOR involves several mechanisms, so far, it is not clear whether butyrate is involved in the prevention of ferroptosis via the regulation of the mTOR pathway. This evidence concerns the gene MTOR and cancer.